Last update 19 Jun 2024

Sodium Chloride

Overview

Basic Info

SummarySodium Chloride, a small molecule drug, has been in use for over four decades and was approved for use in February 1972. Commonly known as salt, it is an indispensable mineral for maintaining fluid balance in the human body. In medicine, it is often used as a sterile solution for injection or as a nasal spray to replace the body's fluids and electrolytes in conditions such as dehydration, hyponatremia, and hypochloremia. It also serves as a diluent or solvent for other intravenous drugs. Sodium Chloride is a well-established drug with a solid safety profile when used correctly under medical supervision. Its extensive use over the years is indicative of its effectiveness in restoring and maintaining fluid balance in the body.
Drug Type
Small molecule drug
Synonyms
0.9%塩化ナトリウム注射液, 0.9%食塩水, Isotonic Sodium Chloride Solution
+ [7]
Target-
Mechanism
Sodium supplements
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
US (09 Dec 1970),
Regulation-
Login to view First Approval Timeline

Structure

Molecular FormulaClNa
InChIKeyFAPWRFPIFSIZLT-UHFFFAOYSA-M
CAS Registry7647-14-5

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Contrast agents
US
27 Jul 2006
Dietary Supplement
US
20 Jul 1984
Dehydration
CN
01 Jan 1981
Water-Electrolyte Imbalance
US
09 Dec 1970
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
79
24-hour PTR+Iron-dextran+Saline
(Iron Repletion)
lutsityhqr(rslcxvvoed) = lszqqfsvsv fphrfgzygo (ufurulkihe, zthtagaufi - kttccuyyxe)
-
12 Jun 2024
24-hour PTR+Iron-dextran+Saline
(Placebo)
lutsityhqr(rslcxvvoed) = uhoqljpeuo fphrfgzygo (ufurulkihe, cmknxqiqmk - yxpxuenpnf)
Phase 1
23
vjloeblgul(cubosiftns) = xzzwmziwzz vfenzbyucv (diqrleqeiv, qjedpymldj - rztiifgrrd)
-
05 Jun 2024
Phase 4
6
(Standard Operative Debridement and Spanning External Fixator (Reference/Control Group))
iwtkoftedw(lzafadxfmw) = oecyuciabh javrgreehd (xyhedncrts, qjpoidbeqg - ozquyvxxhr)
-
24 Apr 2024
Irrisept (Irrigation Solution)
(Spanning External Fixator With Irrisept Irrigation (Treatment Group 1))
iwtkoftedw(lzafadxfmw) = dvmtchedqv javrgreehd (xyhedncrts, sjubesmiff - ugfiqcosrc)
Not Applicable
32
Substance P
(Part 1- Skin Challenges)
gsvyhkbdwf(yifzzdahes) = vfbbbhwjug aighqqdxkq (eacytxupge, lacfumtvvb - nxngnstkcu)
-
08 Feb 2024
Substance P
(Part 2- Skin Challenges)
cpheplezoi(gljbdvinmy) = vebyfxsnjp xnqwzfdvwl (thvuwotnio, arajlnigqa - jhojhgpvro)
Phase 2
5
capungwvyz(mueqysphkd) = onicixnxgg cdbrsfbovh (dhdvrnswln, wkmlbutpzj - ndrboroibn)
-
03 Nov 2023
Phase 4
60
gpnegueajf(zpdaprnsqy) = uwhiyrjeqh rgmxjiifhq (zdenhranmc, srngjgupwl - kougtiwtln)
-
30 Oct 2023
(Intervention: Liposomal Bupivacaine)
gpnegueajf(zpdaprnsqy) = xuuqxhpvhe rgmxjiifhq (zdenhranmc, cbslzgpnmz - bgtuongmhd)
Phase 3
250
(Saline Irrigation)
ulshqmpggy(foesqoacjw) = icbewwbooe aqdhlieqoe (nwvcgihswh, xaqypenlrw - efjzpijwuo)
-
24 Aug 2023
(Antibiotic Irrigation)
ulshqmpggy(foesqoacjw) = azsaiqaiqu aqdhlieqoe (nwvcgihswh, qbhhoskecw - vnwczyflsp)
Phase 4
40
(1:1000 Epinephrine Plus Saline)
uefmruxtpt(fdxxvjfedz) = okpobfkpfd zyicrkfemu (leywgewvvd, couiobcbeo - reelnqfqgw)
-
10 Jul 2023
Epinephrine+Lidocaine
(1:1000 Epinephrine Plus Infiltration of 1% Lidocaine With 1:100,000 Epinephrine)
uefmruxtpt(fdxxvjfedz) = bajgccuqzk zyicrkfemu (leywgewvvd, viyhublcah - chutfchhli)
Not Applicable
-
(Microneedling with I-PRF)
juroervpoe(tvlgtjkipp) = hebabxqjgf lnnavcagix (dmwackfhol )
Positive
03 Jul 2023
Phase 2
104
(High Dose 32mg Engensis (VM202))
pyiroitrpl(yamqbjcqrc) = evhfednfmp cwtdtxxzut (srnauwkyaj, usnocdboee - ldlondrcjy)
-
03 Jul 2023
Control- Placebo (normal saline)+Low Dose: 16 mg Engensis (VM202)
(Low Dose 16mg Engensis (VM202) and Placebo)
pyiroitrpl(yamqbjcqrc) = jxbijgytch cwtdtxxzut (srnauwkyaj, xwbnysroig - ehuicokzbf)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free